Key result
In silico screens for off-target events using an edit distance cutoff of three yielded a sensitivity of 14% and a false discovery rate of 99%, suggesting limited utility for predicting SBO off-target effects.
Why the study?
Steric-blocking oligonucleotides can bind near-complementary sites across the transcriptome causing off-target effects, but these transcriptome-wide events and in silico prediction methods required systematic evaluation.
In silico methods are currently of limited use for predicting the off-target effects of steric-blocking oligonucleotides, as most events occur at high edit distances.
In silico off-target prediction for steric-blocking oligonucleotides shows limited reliability; leaves open need for experimental validation in therapeutic development.
Steric-blocking oligonucleotides (SBOs) are short, single-stranded nucleic acids designed to modulate gene expression by binding to mRNA and blocking access from cellular machinery such as splicing factors. SBOs have the potential to bind to near-complementary sites in the transcriptome, causing off-target effects. In this study, we used RNA-seq to evaluate the off-target differential splicing events of 81 SBOs and differential expression events of 46 SBOs. Our results suggest that differential splicing events are predominantly hybridization-driven, while differential expression events are more common and driven by other mechanisms. We further evaluated the performance of in silico screens for off-target events, and found an edit distance cutoff of three to result in a sensitivity of 14% and false discovery rate of 99%. A machine learning model incorporating splicing predictions substantially improved the ability to prioritize low edit distance hits, increasing sensitivity from 4% to 26% at a fixed FDR. Despite these large improvements in performance, the approach does not detect the majority of events at a false discovery rate below 99%. Our results suggest that in silico methods are currently of limited use for predicting the off-target effects of SBOs.
No takes yet. Share an insight, caveat, or question.
Holgersen et al. (2020) studied Off-target effects of steric-blocking oligonucleotides (n=105). Steric-blocking oligonucleotides (SBOs) vs. Mock-transfected samples was evaluated on Sensitivity and false discovery rate of in silico screens for off-target events using an edit distance cutoff of three. In silico screens for off-target events using an edit distance cutoff of three yielded a sensitivity of 14% and a false discovery rate of 99%, suggesting limited utility for predicting SBO off-target effects.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: